MA53294A - Préparation de bactériophages - Google Patents

Préparation de bactériophages

Info

Publication number
MA53294A
MA53294A MA053294A MA53294A MA53294A MA 53294 A MA53294 A MA 53294A MA 053294 A MA053294 A MA 053294A MA 53294 A MA53294 A MA 53294A MA 53294 A MA53294 A MA 53294A
Authority
MA
Morocco
Prior art keywords
bacteriophage preparation
bacteriophage
preparation
Prior art date
Application number
MA053294A
Other languages
English (en)
Inventor
Jumpei Fujiki
Hidetoshi Higuchi
Hidetomo Iwano
Yutaka Tamura
Masaru Usui
Original Assignee
Incorporated Educational Inst Rakuno Gakuen
Meiji Seika Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incorporated Educational Inst Rakuno Gakuen, Meiji Seika Pharma Co Ltd filed Critical Incorporated Educational Inst Rakuno Gakuen
Publication of MA53294A publication Critical patent/MA53294A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10131—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MA053294A 2018-08-10 2019-08-09 Préparation de bactériophages MA53294A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018151950 2018-08-10

Publications (1)

Publication Number Publication Date
MA53294A true MA53294A (fr) 2022-05-04

Family

ID=69414263

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053294A MA53294A (fr) 2018-08-10 2019-08-09 Préparation de bactériophages

Country Status (8)

Country Link
US (1) US20210290702A1 (fr)
EP (1) EP3834835A4 (fr)
JP (1) JPWO2020032232A1 (fr)
CN (1) CN113038960A (fr)
BR (1) BR112021002417A2 (fr)
CA (1) CA3108051A1 (fr)
MA (1) MA53294A (fr)
WO (1) WO2020032232A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021079435A1 (fr) * 2019-10-23 2021-04-29 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 Composition bactériophage
WO2021079986A1 (fr) * 2019-10-23 2021-04-29 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 Composition bactériophage
WO2021157732A1 (fr) * 2020-02-07 2021-08-12 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 Agent destiné à être utilisé comme bactériophage
CN111893198B (zh) * 2020-07-16 2021-04-20 广东省微生物研究所（广东省微生物分析检测中心） 用于银白色葡萄球菌鉴定的特异性分子靶标、检测引物组及其快速检测方法
CN115261334B (zh) * 2021-07-02 2023-06-27 青岛诺安百特生物技术有限公司 一株葡萄球菌噬菌体、噬菌体制剂及其在防治葡萄球菌感染的疾病中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5647232A (en) 1979-09-25 1981-04-28 Honda Motor Co Ltd Ring rolling apparatus
DK1023903T3 (da) 1999-01-26 2004-05-10 Akzo Nobel Nv Anvendelse af levende, svækkede bakterier til fremstilling af en submukös vaccine
JP2004283003A (ja) 2003-01-31 2004-10-14 Rikogaku Shinkokai バクテリオファージによる大腸菌の検出
KR101021041B1 (ko) * 2008-06-09 2011-03-15 주식회사 인트론바이오테크놀로지 유효성분으로 박테리오파지를 포함하는 선박 평형수 처리용조성물 및 이를 이용한 선박 평형수에 존재하는박테리아의 생물학적 제거 방법
EP2307557B1 (fr) * 2008-07-03 2017-03-01 The Rockefeller University Lysine chimérique de bactériophage présentant une activité contre les bactéries staphylocoques
JP5720045B2 (ja) * 2008-12-26 2015-05-20 国立大学法人東京工業大学 スタフィロコッカス・アウレウス溶菌性バクテリオファージ
US20170157186A1 (en) * 2015-12-02 2017-06-08 Smart Phage, Inc. Phage to treat bacteria on skin
CN107779439B (zh) * 2016-08-24 2021-02-02 菲吉乐科(南京)生物科技有限公司 新的葡萄球菌噬菌体及其组合物、制备方法和应用
US10695386B2 (en) * 2017-05-11 2020-06-30 Shayne K. Morris Skin microbiome colonizer formulations and methods for use
CN107779440B (zh) * 2017-11-02 2019-10-18 青岛诺安百特生物技术有限公司 一种葡萄球菌噬菌体及其在葡萄球菌感染中的应用
WO2021079435A1 (fr) * 2019-10-23 2021-04-29 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 Composition bactériophage
EP4356919A1 (fr) * 2021-08-25 2024-04-24 Incorporated Educational Institution Rakuno Gakuen Composition pour améliorer la sensibilité aux médicaments d'un médicament antibactérien contre staphylococcus aureus résistant à la méthicilline (mrsa), composition pour traiter ou prévenir une infection par mrsa, et composition pour réduire la virulence de mrsa

Also Published As

Publication number Publication date
US20210290702A1 (en) 2021-09-23
BR112021002417A2 (pt) 2021-05-04
EP3834835A4 (fr) 2022-05-04
JPWO2020032232A1 (ja) 2021-08-10
WO2020032232A1 (fr) 2020-02-13
CA3108051A1 (fr) 2020-02-13
CN113038960A (zh) 2021-06-25
EP3834835A1 (fr) 2021-06-16

Similar Documents

Publication Publication Date Title
CA200048S (fr) Bague
MA54714A (fr) Formulation de nicotine
MA53294A (fr) Préparation de bactériophages
DK3794042T3 (da) Anti-muc1-exatecet-antistof-lægemiddelkonjugat
MA50657A (fr) Formulations de niraparib
ES2972844T3 (es) Preparación farmacéutica
CA185200S (fr) Bague
MA50068A (fr) Formulations de copanlisib
DK3793375T3 (da) Brændingssystem
DE112018002289A5 (de) Strumpfanzieher
DK3430923T3 (da) Medicinsk strømpe
DK3627028T3 (da) Fitting
DK3496106T3 (da) Medicinsk forbinding
ES2747993T8 (es) Composiciones farmacéuticas de liberación prolongada de levetiracetam
CL2019000305A1 (es) Ingrediente de alimento
TWI846758B (zh) 桌台
UA40062S (uk) Стіл
JP1628025S (ja) 検眼器
JP1628024S (ja) 検眼器
CA185218S (fr) Bague
CA185216S (fr) Bague
ES1216385Y (es) Salmorejo natural de preparación instantánea
TH190849S (th) แหวน
UA39305S (uk) Мультиварка-скороварка
TH185093B (th) โต๊ะ